Sign in

CIK 0001528172 · Non-accelerated filer<br>Smaller reporting company

ENDONOVO THERAPEUTICS, INC.

Sign in to watch
Ticker
ENDV
Exchange
OTC
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
452552528
Phone
(800) 489-4774
Business address
6320 CANOGA AVENUE, 15TH FLOOR, WOODLAND HILLS, CA, 91367
Former names
Hanover Portfolio Acquisitions, Inc.
  1. 4 Open-market buy President bought 14,000 shares at an average $0.06 ($850)
  2. 4 Open-market buy President bought 57,000 shares at an average $0.06 ($3,419)
  3. D Other Notice of Sales of Unregistered Securities
  4. 8-K Event Material agreement
  5. 4 Open-market buy President bought 35,000 shares at an average $0.06 ($2,200)
  6. 8-K Event Material agreement · Acquisition or sale completed · Shareholder rights changed
  7. 4 Open-market buy President bought 64,000 shares at an average $0.05 ($3,202)
  8. 4 Open-market buy President bought 68,000 shares at an average $0.06 ($3,824)
  9. 4 Open-market buy President bought 21,000 shares at an average $0.06 ($1,230)
  10. 4 Open-market buy President bought 82,000 shares at an average $0.05 ($4,477)
  11. 4 Open-market buy President bought 52,000 shares at an average $0.06 ($3,174)
  12. 4 Open-market buy President bought 32,000 shares at an average $0.06 ($2,069)
  13. 4 Open-market buy President bought 21,000 shares at an average $0.06 ($1,262)
  14. 4 Open-market buy President bought 18,000 shares at an average $0.05 ($945)
  15. 4 Open-market buy President bought 18,000 shares at an average $0.05 ($819)
  16. 4 Open-market buy President bought 27,000 shares at an average $0.05 ($1,316)
  17. 4 Open-market buy President bought 36,000 shares at an average $0.05 ($1,727)
  18. 4 Open-market buy President bought 35,000 shares at an average $0.05 ($1,714)
  19. 10-Q/A Report 10-Q/A
  20. 10-Q Report Quarterly Report

Page 13 of 26 · 502 filings